Trials / Completed
CompletedNCT02116426
Copeptin Testing During Pre-hospital Care in the Treatment of Chest Pain Suggestive of Acute Coronary Syndrome
The Role of Copeptin Testing During Pre-hospital Care in the Treatment of Chest Pain Suggestive of Acute Coronary Syndrome
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 320 (actual)
- Sponsor
- Centre Hospitalier Universitaire de Nīmes · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The main objective of our study is to evaluate the diagnostic value of copeptin testing in association with troponin HS testing during pre-hospital care (ambulance care) in the treatment of patients whose pattern of use is the occurrence chest pain suggestive of ACS but not ST+.
Detailed description
The secondary objectives of this study are to: A. Evaluate the diagnostic value of determination of copeptin testing in pre-hospital care in another diagnosis; B. Assess the prognostic value of copeptin assay on vital prognosis at day 28; C. Evaluate the kinetics of copeptin and troponin HS between initial ambulance care and arrival at the emergency department; D. Evaluate the potential impact of copeptin testing on pre-hospital patient care; E. Assess the economic impact of pre-hospital copeptin testing in terms of hospital stays and optimizing ambulance movements.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BIOLOGICAL | Blood work in the ambulance | Blood sample for copeptin and troponin HS testing is taken during ambulance care. |
| BIOLOGICAL | Blood work upon arrival in the emergency room | Blood in drawn for copeptin and troponin HS testing upon arrival in the emergency room. |
| BIOLOGICAL | Blood work at 3 hours post-arrival in the emergency room | Blood is drawn for troponin HS testing 3 hours after the patient's arrival in the emergency room. |
Timeline
- Start date
- 2015-07-29
- Primary completion
- 2017-08-01
- Completion
- 2017-08-01
- First posted
- 2014-04-16
- Last updated
- 2018-01-03
Locations
2 sites across 1 country: France
Source: ClinicalTrials.gov record NCT02116426. Inclusion in this directory is not an endorsement.